PT - JOURNAL ARTICLE AU - Camelo, Sergio AU - Ciocan, Florin AU - Iancu, Dan A. AU - Warnes, Xavier S. AU - Zoumpoulis, Spyros I. TI - Quantifying the Benefits of Targeting for Pandemic Response AID - 10.1101/2021.03.23.21254155 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.23.21254155 4099 - http://medrxiv.org/content/early/2021/12/15/2021.03.23.21254155.short 4100 - http://medrxiv.org/content/early/2021/12/15/2021.03.23.21254155.full AB - Problem definition To respond to pandemics such as COVID-19, policy makers have relied on interventions that target specific population groups or activities. Since targeting is potentially contentious, rigorously quantifying its benefits is critical for designing effective and equitable pandemic control policies.Methodology/results We propose a flexible modeling framework and a set of associated algorithms that compute optimally targeted, time-dependent interventions that coordinate across two dimensions of heterogeneity: age of different groups and the specific activities that individuals engage in during the normal course of a day. We showcase a complete implementation focused on the Île-de-France region of France, based on commonly available public data. We find that targeted policies generate substantial complementarities that lead to Pareto improvements, reducing the number of deaths and the economic losses, as well as the time in confinement for each age group. Optimized dual-targeted policies are interpretable: by fitting decision trees to our raw policy’s decisions across many problem instances, we find that a feature corresponding to the ratio of marginal economic value prorated by social contacts is highly salient in explaining the confinements that any group - activity pair experiences. We also quantify the impact of fairness requirements that explicitly limit the differential treatment of distinct groups, and find that satisfactory trade-offs are achievable through limited targeting.Implications Given that some amount of targeting of activities and age groups is already in place in real-world pandemic responses, our framework highlights the significant benefits in explicitly and transparently modelling targeting and identifying the interventions that rigorously optimize overall societal welfare.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been followed. No necessary IRB/ethics committee approvals, to the best of our knowledge.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are public and URL references to the datasets are included in the manuscript.